Literature DB >> 7668257

Analysis of phenotypic features and FGFR2 mutations in Apert syndrome.

W J Park1, C Theda, N E Maestri, G A Meyers, J S Fryburg, C Dufresne, M M Cohen, E W Jabs.   

Abstract

A phenotypic and genotypic survey was conducted on 36 Apert syndrome patients. In all but one patient, an FGFR2 mutation, either S252W or P253R, was found in exon IIIa (exon U or 7). The frequency was 71% and 26%, for the mutations S252W and P253R, respectively. These mutations occur in the linker region between immunoglobulin-like domains II and III, which are involved in activation of the receptor by ligand binding and dimerization. The fact that one patient did not have a mutation in the same exon suggests further genetic heterogeneity in Apert syndrome. The frequencies of occurrence or means for measurements of 29 different clinical features (including severity of craniofacial features, syndactyly of the hands and feet, and multisystem involvement) were determined for all patients and for the two subgroups defined by their mutations. Comparison between the subgroups for the different clinical features was performed and suggested no statistically significant differences. These results are not unexpected, because the two common mutations for Apert syndrome alter FGFR2 at adjacent amino acids that are likely to have similar biological, and therefore phenotypic, consequences.

Entities:  

Mesh:

Year:  1995        PMID: 7668257      PMCID: PMC1801532     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  23 in total

1.  A study of parental age effects on the occurrence of fresh mutations for the Apert syndrome.

Authors:  J D Erickson; M M Cohen
Journal:  Ann Hum Genet       Date:  1974-07       Impact factor: 1.670

2.  FGFR2 mutations in Pfeiffer syndrome.

Authors:  E Lajeunie; H W Ma; J Bonaventure; A Munnich; M Le Merrer; D Renier
Journal:  Nat Genet       Date:  1995-02       Impact factor: 38.330

3.  A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome.

Authors:  M Muenke; U Schell; A Hehr; N H Robin; H W Losken; A Schinzel; L J Pulleyn; P Rutland; W Reardon; S Malcolm
Journal:  Nat Genet       Date:  1994-11       Impact factor: 38.330

4.  Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2.

Authors:  E W Jabs; X Li; A F Scott; G Meyers; W Chen; M Eccles; J I Mao; L R Charnas; C E Jackson; M Jaye
Journal:  Nat Genet       Date:  1994-11       Impact factor: 38.330

5.  Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome.

Authors:  A O Wilkie; S F Slaney; M Oldridge; M D Poole; G J Ashworth; A D Hockley; R D Hayward; D J David; L J Pulleyn; P Rutland
Journal:  Nat Genet       Date:  1995-02       Impact factor: 38.330

6.  Identical mutations in the FGFR2 gene cause both Pfeiffer and Crouzon syndrome phenotypes.

Authors:  P Rutland; L J Pulleyn; W Reardon; M Baraitser; R Hayward; B Jones; S Malcolm; R M Winter; M Oldridge; S F Slaney
Journal:  Nat Genet       Date:  1995-02       Impact factor: 38.330

7.  Germinal mosaicism in Apert syndrome.

Authors:  J E Allanson
Journal:  Clin Genet       Date:  1986-05       Impact factor: 4.438

8.  Identification of the cystic fibrosis gene: chromosome walking and jumping.

Authors:  J M Rommens; M C Iannuzzi; B Kerem; M L Drumm; G Melmer; M Dean; R Rozmahel; J L Cole; D Kennedy; N Hidaka
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

9.  Mutations in FGFR1 and FGFR2 cause familial and sporadic Pfeiffer syndrome.

Authors:  U Schell; A Hehr; G J Feldman; N H Robin; E H Zackai; C de Die-Smulders; D H Viskochil; J M Stewart; G Wolff; H Ohashi
Journal:  Hum Mol Genet       Date:  1995-03       Impact factor: 6.150

10.  Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3.

Authors:  P L Tavormina; R Shiang; L M Thompson; Y Z Zhu; D J Wilkin; R S Lachman; W R Wilcox; D L Rimoin; D H Cohn; J J Wasmuth
Journal:  Nat Genet       Date:  1995-03       Impact factor: 38.330

View more
  67 in total

1.  Prominent basal emissary foramina in syndromic craniosynostosis: correlation with phenotypic and molecular diagnoses.

Authors:  C D Robson; J B Mulliken; R L Robertson; M R Proctor; D Steinberger; P D Barnes; A McFarren; U Müller; D Zurakowski
Journal:  AJNR Am J Neuroradiol       Date:  2000-10       Impact factor: 3.825

2.  Mesodermal expression of Fgfr2S252W is necessary and sufficient to induce craniosynostosis in a mouse model of Apert syndrome.

Authors:  Greg Holmes; Claudio Basilico
Journal:  Dev Biol       Date:  2012-06-01       Impact factor: 3.582

Review 3.  Fibroblast growth factor receptor mutations and craniosynostosis: three receptors, five syndromes.

Authors:  A O Wilkie
Journal:  Indian J Pediatr       Date:  1996 May-Jun       Impact factor: 1.967

4.  A splicing switch and gain-of-function mutation in FgfR2-IIIc hemizygotes causes Apert/Pfeiffer-syndrome-like phenotypes.

Authors:  M K Hajihosseini; S Wilson; L De Moerlooze; C Dickson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

5.  Differential effects of FGFR2 mutations on syndactyly and cleft palate in Apert syndrome.

Authors:  S F Slaney; M Oldridge; J A Hurst; G M Moriss-Kay; C M Hall; M D Poole; A O Wilkie
Journal:  Am J Hum Genet       Date:  1996-05       Impact factor: 11.025

6.  Impaired FGF signaling contributes to cleft lip and palate.

Authors:  Bridget M Riley; M Adela Mansilla; Jinghong Ma; Sandra Daack-Hirsch; Brion S Maher; Lisa M Raffensperger; Erilynn T Russo; Alexandre R Vieira; Catherine Dodé; Moosa Mohammadi; Mary L Marazita; Jeffrey C Murray
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-06       Impact factor: 11.205

7.  A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome.

Authors:  M Muenke; K W Gripp; D M McDonald-McGinn; K Gaudenz; L A Whitaker; S P Bartlett; R I Markowitz; N H Robin; N Nwokoro; J J Mulvihill; H W Losken; J B Mulliken; A E Guttmacher; R S Wilroy; L A Clarke; G Hollway; L C Adès; E A Haan; J C Mulley; M M Cohen; G A Bellus; C A Francomano; D M Moloney; S A Wall; A O Wilkie
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

8.  Presence of the Apert canonical S252W FGFR2 mutation in a patient without severe syndactyly.

Authors:  M R Passos-Bueno; A Richieri-Costa; A L Sertié; A Kneppers
Journal:  J Med Genet       Date:  1998-08       Impact factor: 6.318

9.  Postnatal brain and skull growth in an Apert syndrome mouse model.

Authors:  Cheryl A Hill; Neus Martínez-Abadías; Susan M Motch; Jordan R Austin; Yingli Wang; Ethylin Wang Jabs; Joan T Richtsmeier; Kristina Aldridge
Journal:  Am J Med Genet A       Date:  2013-03-12       Impact factor: 2.802

10.  FGFR2 exon IIIa and IIIc mutations in Crouzon, Jackson-Weiss, and Pfeiffer syndromes: evidence for missense changes, insertions, and a deletion due to alternative RNA splicing.

Authors:  G A Meyers; D Day; R Goldberg; D L Daentl; K A Przylepa; L J Abrams; J M Graham; M Feingold; J B Moeschler; E Rawnsley; A F Scott; E W Jabs
Journal:  Am J Hum Genet       Date:  1996-03       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.